Literature DB >> 1553577

Cytokines and cytotoxic agents in renal cell carcinoma: a review.

M Stahl1, H J Wilke, S Seeber, H J Schmoll.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1553577

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  5 in total

1.  A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinoma.

Authors:  R S Witte; T Leong; M S Ernstoff; R L Krigel; M M Oken; J Harris; D C Tormey; D L Trump
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

Review 2.  Interleukin-2 and interferon in renal cell carcinoma.

Authors:  P Wersäll
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

Review 3.  Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.

Authors:  Ruth Whittington; Diana Faulds
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

Review 4.  Cytokine combinations in immunotherapy for solid tumors: a review.

Authors:  K M Heaton; E A Grimm
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

5.  IL-2 in combination with IFN- alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial.

Authors:  J Atzpodien; H Kirchner; H J Illiger; B Metzner; D Ukena; H Schott; P J Funke; M Gramatzki; S Jürgenson; T Wandert; T Patzelt; M Reitz
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.